Skip to main content
. 2009 Oct 26;27(34):5816–5822. doi: 10.1200/JCO.2009.23.7420

Fig 2.

Fig 2.

(A) Overall survival (OS) rates based on the baseline European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Lung Cancer 13 (EORTC QLQ LC-13) dyspnea score (5-year OS of 15% v 19% for EORTC QLQ LC-13 dyspnea scores above and below the median level, respectively). (B) OS rates based on the baseline EORTC QLQ-C30 physical functioning score (5-year OS of 23% v 12% for EORTC QLQ-C30 physical functioning scores above and below the median level, respectively).